ALPN - Alpine Immune Sciences Inc. (ALPN) CEO Mitchell Gold on Q4 2020 Results - Earnings Call Transcript
Alpine Immune Sciences, Inc. (ALPN) Q4 2020 Earnings Conference Call March 18, 2021 4:30 PM ET Company Participants Alex Sharif - Director, Investor Relations and Corporate Development Mitchell Gold - Executive Chairman and Chief Executive Officer Stanford Peng - President and Head of Research and Development Paul Rickey - Chief Financial Officer Conference Call Participants Ted Tenthoff - Piper Sandler Mark Breidenbach - Oppenheimer Joe Pantginis - H.C. Wainwright Presentation Operator Good afternoon, ladies and gentlemen, and thank you for joining the Alpine Immune Sciences Fourth Quarter 2020 Financial Results and Corporate Update Conference Call. Currently all participants are in a listen-only mode. Following the management prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this conference call is being recorded today, Thursday, March 18th, 2021. I would now like to introduce Alex Sharif, Director, Investor Relations and Corporate Development. Please go ahead. Alex Sharif Thank
For further details see:
Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q4 2020 Results - Earnings Call Transcript